Immunotherapy represented by PD-1/PD-L1 inhibitor and chimeric antigen receptor T cell (CAR-T) has shown satisfactory targeting ability and curative effect in cancer therapy, implying its promising prospect in treatment (5). The gene discussed is CD274; the disease is cancer.